There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Verona Abdelmeseh, PharmD
Advertisement
Articles by Verona Abdelmeseh, PharmD
Advertisement
Latest Updated Articles
Overview of PARP Inhibitors in the Treatment of Ovarian CancerOctober 11th 2021
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
3
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
4
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
5